ClassID:

21647

A61K2300/00 - page 52 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#15301
20090048150
2009-02-19

Materials and methods for the detection of nitrated fibrinogen

#15302
20090047371
2009-02-19

PHARMACEUTICAL COMPOSITION COMPRISING CURCUMIN AND RESVERATROL AND USES THEREOF IN MEDICAL FIELD

#15303
20090047367
2009-02-19

Pharmaceutical composition for improving anxious behaviors of animals and method for preparing the same

#15304
20090047365
2009-02-19

Novel Concomitant Use of Sulfonamide Compound with Anti-Cancer Agent

#15305
20090047362
2009-02-19

Method for in-vitro stabilization of heavy metals

#15306
20090047360
2009-02-19

Bone morphogenic protein binding peptide

#15307
20090047356
2009-02-19

TISSUE FACTOR COMPOSITIONS AND METHODS

#15308
20090047343
2009-02-19

Method for stabilizing phenylephrine

#15309
20090047340
2009-02-19

LIPOSOMAL REDUCED GLUTATHIONE AND 1-ARGININE, INCLUDING WITH OTHER INGREDIENT(S), CAPABLE OF MULTIPATH ADMINISTRATION FOR REVERSAL AND PREVENTION OF OBESITY AND FOR MITOCHONDRIAL BIOGENESIS

#15310
20090047337
2009-02-19

Method of administering a cationic liposomal preparation

#15311
20090047307
2009-02-19

Chemo-immunotherapy method

#15312
20090047306
2009-02-19

ADJUVANT COMPOSITIONS

#15313
20090047305
2009-02-19

METHOD OF PRODUCING PROANTHOCYANIDIN OLIGOMER

#15314
20090047304
2009-02-19

Composition For Body Fat Reduction

#15315
20090047295
2009-02-19

Methods and Compositions for Reducing Stemness in Oncogenesis

#15316
20090047288
2009-02-19

Glucan compositions and methods of enhancing CR3 dependent neutrophil-mediated cytotoxicity

#15317
20090047285
2009-02-19

Antibodies that bind the glutamate ligand binding region of Notch1

#15318
20090047278
2009-02-19

Novel Combinational Use of Sulfonamide Compound

#15319
20090047248
2009-02-19

Triazolyl macrocyclic hepatitis C serine protease inhibitors

#15320
20090047247
2009-02-19

Pyrrolidine Derivatives

#15321
20090047243
2009-02-19

COMBINATIONS FOR THE TREATMENT OF B-CELL PROLIFERATIVE DISORDERS

#15322
20090047242
2009-02-19

CONDITIONED BLOOD COMPOSITION AND METHOD FOR ITS PRODUCTION

#15323
20090047240
2009-02-19

Chaperonin 10-induced immunomodulation

#15324
20090047239
2009-02-19

Stabilised IL-21 Compositions

#15325
20090047234
2009-02-19

Compositions for nasal delivery

#15326
20090045121
2009-02-19

Dialysis Solution Preparation Water, Dialysis Solution Using Such Water, Method of Producing Dialysis Solution, and Dialysis Equipment

#15327
20090043379
2009-02-12

DRUG DELIVERY SYSTEMS FOR THE PREVENTION AND TREATMENT OF VASCULAR DISEASES

#15328
20090042983
2009-02-12

Use of L-carnitine for the treatment of cardiovascular diseases

#15329
20090042979
2009-02-12

Novel Statin Pharmaceutical Compositions and Related Methods of Treatment

#15330
20090042968
2009-02-12

THERAPEUTIC COMPOSITIONS FOR INTRANASAL ADMINISTRATION OF KETOROLAC

#15331
20090042940
2009-02-12

METHODS AND COMPOSITIONS USING CHOLINESTERASE INHIBITORS

#15332
20090042939
2009-02-12

Methods and Compositions Using Cholinesterase Inhibitors

#15333
20090042936
2009-02-12

Compositions and Methods for Treating or Controlling Anterior-Segment Inflammation

#15334
20090042915
2009-02-12

PREVENTIVE OR THERAPEUTIC AGENT FOR HERPESVIRUS-RELEATED DISEASE

#15335
20090042887
2009-02-12

Methods for Preventing or Reducing the Number of Gout Flares Using Xanthine Oxidoreductase Inhibitors and Anti-Inflammatory Agents

#15336
20090042845
2009-02-12

Suppression and prevention of tumors

#15337
20090042835
2009-02-12

COMPOSITIONS AND METHODS FOR AMELIORATING HYPERLIPIDEMIA

#15338
20090042834
2009-02-12

Stabilized glycosaminoglycan preparations and related methods

#15339
20090042833
2009-02-12

PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF OSTEOARTHRITIS CONTAINING CLODRONIC ACID AND HYALURONIC ACID

#15340
20090042827
2009-02-12

Antiviral oligonucleotides targeting HBV

#15341
20090042823
2009-02-12

USES OF BROAD SPECTRUM RNAI THERAPEUTICS AGAINST INFLUENZA

#15342
20090042821
2009-02-12

STABLE DOSAGE FORMS OF SPIRO AND DISPIRO 1,2,4-TRIOXOLANE ANTIMALARIALS

#15343
20090042817
2009-02-12

Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases

#15344
20090042806
2009-02-12

Transglutaminase inhibitors and methods of use thereof

#15345
20090042801
2009-02-12

Method for inhibiting infection and reproduction of influenza type A WSN virus

#15346
20090042781
2009-02-12

Methods for Treating Diabetes

#15347
20090042729
2009-02-12

Liquid kelp formulation with or without enhanced shelf life, and method of making

#15348
20090042047
2009-02-12

Polyamides

#15349
20090041873
2009-02-12

Anti-diabetic extract isolated from and , and methods of using same

#15350
20090041872
2009-02-12

Encapsulated vaccinium extracts with balanced gastrointestinal release

#15351
20090041871
2009-02-12

Composition for controlling the respiratory effect of inhaled pollutants and allergens

#15352
20090041870
2009-02-12

Annatto extract compositions including tocotrienols and tocopherols and methods of use

#15353
20090041863
2009-02-12

Use of GSK3 inhibitors in combination with radiation therapies

#15354
20090041860
2009-02-12

ORALLY-DISPERSIBLE PHARMACEUTICAL COMPOSITIONS

#15355
20090041857
2009-02-12

Analgesic cream

#15356
20090041856
2009-02-12

Methods for promoting hair growth

#15357
20090041854
2009-02-12

PARATHYROID AND THYMUS TRANSPLANTATION IN DIGEORGE SYNDROME SUBJECTS

#15358
20090041853
2009-02-12

Therapeutic bio platinum complex

#15359
20090041849
2009-02-12

DISSOLUTION AIDS FOR ORAL PEPTIDE DELIVERY COMPRISING A BIGUANIDE

#15360
20090041834
2009-02-12

Compositions and methods for treating lymphoma

#15361
20090041810
2009-02-12

Immunostimulating polyphosphazene compounds for intradermal immunization

#15362
20090041803
2009-02-12

Dioscorea extracts for enhancing immune system

#15363
20090041788
2009-02-12

Apo-2L receptor agonist and CPT-11 synergism

#15364
20090041779
2009-02-12

Aldosterone induced elastin production

#15365
20090041766
2009-02-12

Method for using antibodies for inhibiting blood coagulation

#15366
20090041760
2009-02-12

RETROVIRAL IMMUNOTHERAPY

#15367
20090041759
2009-02-12

Materials and methods for treating ocular-related disorders

#15368
20090041743
2009-02-12

SPERM-BLOCKING AGENT COMPOSITION WITH CONTRACEPTIVE EFFECT

#15369
20090041739
2009-02-12

Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells

#15370
20090041738
2009-02-12

Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells

#15371
20090041731
2009-02-12

Treatment for Diabetes

#15372
20090041721
2009-02-12

Arylalkoxyl hepatitis C virus protease inhibitors

#15373
20090041715
2009-02-12

Epothilone Combinations

#15374
20090041675
2009-02-12

Organic compounds

#15375
20090036544
2009-02-05

METHODS AND COMPOSITIONS FOR INHIBITING THE PROLIFERATION OF PROSTATE CANCER CELLS

#15376
20090036520
2009-02-05

Combinations of vasoprotective agents and formulations containing them

#15377
20090036519
2009-02-05

Peroxisome proliferator activated receptor ligand and process for producing the same

#15378
20090036517
2009-02-05

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#15379
20090036495
2009-02-05

Combinations Comprising Alpha-2-Delta Ligands and Ep4 Receptor Antagonists

#15380
20090036487
2009-02-05

Combinations

#15381
20090036468
2009-02-05

PHARMACEUTICAL COMPOSITIONS CONTAINING DOPAMINE RECEPTOR LIGANDS AND METHODS OF TREATMENT USING DOPAMINE RECEPTOR LIGANDS

#15382
20090036465
2009-02-05

COMBINATION THERAPY FOR PULMONARY ARTERIAL HYPERTENSION

#15383
20090036458
2009-02-05

ENDOPARASITICIDAL TOPICAL COMPOSITIONS

#15384
20090036435
2009-02-05

Pharmaceutical Compounds

#15385
20090036432
2009-02-05

Combinations of AT1-antagonists, amiloride or triamterine, and a diuretic

#15386
20090036416
2009-02-05

Novel CXCR4 Antagonist and Use Thereof

#15387
20090036415
2009-02-05

Identification and treatment of estrogen responsive prostate tumors

#15388
20090036412
2009-02-05

Methods and compositions for inhibition of angiogenesis

#15389
20090036411
2009-02-05

MODULATION OF CELL FATES AND ACTIVITIES BY PHTHALAZINEDIONES

#15390
20090036408
2009-02-05

Compositions and methods for combination antiviral therapy

#15391
20090036392
2009-02-05

Composition comprising biodegradable hydrating ceramics for controlled drug delivery

#15392
20090036390
2009-02-05

Compositions and methods for treating neoplastic diseases

#15393
20090036384
2009-02-05

INCREASING PREGNANCY RATES

#15394
20090036368
2009-02-05

Therapeutic Combination

#15395
20090036361
2009-02-05

Use of Blood Coagulation Factor XIII for Treating Hemophilia A

#15396
20090036360
2009-02-05

Medicament containing activated antithrombin III

#15397
20090036355
2009-02-05

Antisense Modulation of PTP1B Expression

#15398
20090036352
2009-02-05

DRUG DELIVERY SYSTEMS FOR THE PREVENTION AND TREATMENT OF VASCULAR DISEASES COMPRISING RAPAMYCIN AND DERIVATIVES THEREOF

#15399
20090035397
2009-02-05

METHODS AND COMPOSITIONS FOR IMPROVING CARDIOVASCULAR RISK FACTORS AND METABOLIC RISK FACTORS THAT CAUSE SYNDROME X

#15400
20090035394
2009-02-05

USE OF DNA-PK INHIBITION TO SENSITISE ATM DEFICIENT CANCERS TO DNA-DAMAGING CANCER THERAPIES

#15401
20090035393
2009-02-05

Fast acting inhibitor of gastric acid secretion

#15402
20090035391
2009-02-05

Nasal irrigation solutions and methods of using same

#15403
20090035390
2009-02-05

Compositions containing zinc salts for coating medical articles

#15404
20090035385
2009-02-05

COMPOSITIONS INCLUDING IRON

#15405
20090035383
2009-02-05

Scavenger of in vivo harmful reactive oxygen species and/or free radicals

#15406
20090035382
2009-02-05

METHOD AND COMPOUND FOR THE TREATMENT OF ARTICULAR DISEASES OR ARTICULAR PAIN, OR FOR THE TREATMENT OF SKIN FOR AESTHETIC OR OTHER PURPOSES, AND THE METHOD OF PREPARATION OF THE COMPOUND

#15407
20090035371
2009-02-05

Tablet with remedial composition and methods for treating medical disorders and ailments

#15408
20090035366
2009-02-05

Nanoparticulate benzothiophene formulations

#15409
20090035362
2009-02-05

Compositions including androgen receptor degradation (ARD) enhancers and methods of prophylactic or therapeutic treatment of skin disorders and hair loss

#15410
20090035339
2009-02-05

Methods of Inactivating Viruses

#15411
20090035318
2009-02-05

METHOD AND COMPOSITION FOR INCREASING THE ENGRAFTMENT EFFICIENCY OF STEM CELLS

#15412
20090035315
2009-02-05

Method of Improving Treatments in Rheumatic and Arthritic Diseases

#15413
20090035308
2009-02-05

Methods for using and identifying modulators of Delta-like 4

#15414
20090035304
2009-02-05

Use of TGF-β antagonists to limit nephrotoxicity of immunosuppressive agents

#15415
20090035292
2009-02-05

Use of phosphatases to treat neuroblastomas and medulloblastomas

#15416
20090035289
2009-02-05

DRY PLATELET COMPOSITION

#15417
20090035281
2009-02-05

COMBINATION OF INTERLEUKIN-6 ANTAGONISTS AND ANTIPROLIFERATIVE DRUGS

#15418
20090035276
2009-02-05

USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC TREATMENT

#15419
20090035274
2009-02-05

TREATMENT AND/OR PREVENTION OF CANCER AND/OR ARTHRITIS

#15420
20090035273
2009-02-05

Combination treatment method with interferon-tau

#15421
20090035272
2009-02-05

Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors

#15422
20090035271
2009-02-05

TETRAZOLYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS

#15423
20090035270
2009-02-05

COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF alpha

#15424
20090035269
2009-02-05

Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer

#15425
20090035268
2009-02-05

TETRAZOLYL ACYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS

#15426
20090035263
2009-02-05

Method for reducing the likelihood of spontaneous abortion presenting a sign or symptom of threatened abortion

#15427
20090035262
2009-02-05

COMPOSITIONS AND METHODS FOR HEALTHY PREGNANCY

#15428
20090035258
2009-02-05

METHODS OF TREATING CANCER BY ADMINISTERING HUMAN IL-18 COMBINATIONS

#15429
20090035252
2009-02-05

Method of inducing a CTL response

#15430
20090035250
2009-02-05

Compositions and methods for treating cavity conditions

#15431
20090035232
2009-02-05

Fixed-dose association of phytate and zinc

#15432
20090035224
2009-02-05

Methods of Using Albuterol and Calcium Activated Potassium Channel Openers

#15433
20090035221
2009-02-05

Methods and Compositions for Treatment of Erectile Dysfunction

#15434
20090030525
2009-01-29

METHOD FOR RESTORING A DAMAGED OR DEGENERATED INTERVERTEBRAL DISC

#15435
20090030183
2009-01-29

Interferon Beta-Like Molecules

#15436
20090030075
2009-01-29

Remedy for and Method of Treating Ischemic Cerebral Stroke

#15437
20090030072
2009-01-29

PHARMACEUTICAL COMBINATION OF OPIOID AND PROSTAGLANDIN COMPOUND

#15438
20090030067
2009-01-29

Anti-proliferative combination therapy comprising satraplatin or jm118 and a taxane

#15439
20090030063
2009-01-29

Combined pharmaceutical preparation for treatment of type 2 diabetes

#15440
20090030059
2009-01-29

Pharmaceutical composition for external use

#15441
20090030055
2009-01-29

PKC activation as a means for enhancing sAPPALPHA secretion and improving cognition using bryostatin type compounds

#15442
20090030005
2009-01-29

Combinations for the treatment of cancer

#15443
20090029990
2009-01-29

Dihydropteridinones in the treatment of respiratory diseases

#15444
20090029984
2009-01-29

SYNERGISTIC COMBINATION FOR THE TREATMENT OF PAIN (CANNABINOID RECEPTOR AGONIST AND OPIOID RECEPTOR AGONIST)

#15445
20090029967
2009-01-29

ADENOSINE A2A RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXTRA-PYRAMIDAL SYNDROME AND OTHER MOVEMENT DISORDERS

#15446
20090029966
2009-01-29

COMBINATION THERAPY WITH PARP INHIBITORS

#15447
20090029959
2009-01-29

Antiglucocorticoid Therapy for the Prevention of Neurological Damage in Premature Infants

#15448
20090029956
2009-01-29

Substance mixture

#15449
20090029954
2009-01-29

PROGESTERONE-RECEPTOR ANTAGONIST FOR USE IN BRCA ALONE OR AS COMBINATION WITH ANTIESTROGEN

#15450
20090029922
2009-01-29

Use of S1P receptor agonists in heart diseases

#15451
20090029920
2009-01-29

Methods and compositions for treating ocular disorders

#15452
20090029467
2009-01-29

Method for targeting lysosomal enzymes

#15453
20090029028
2009-01-29

Mixture of iron and copper salts masking metallic taste

#15454
20090028969
2009-01-29

Compostion for treating skin

#15455
20090028963
2009-01-29

Polyphenol coxib combinations and methods

#15456
20090028962
2009-01-29

Methods and Compositions for Enhancing Iron Absorption

#15457
20090028933
2009-01-29

COMPOSITIONS AND METHODS FOR TREATING LYMPHOMA

#15458
20090028930
2009-01-29

BRUISE AMELIORATION COMPOSITION AND METHOD OF USE

#15459
20090028918
2009-01-29

Gynecological pharmaceutics- containing microspherical vascular suppository of sodium alginate and its preparation method

#15460
20090028908
2009-01-29

METHODS FOR TREATING NEUROGENIC INFLAMMATION

#15461
20090028896
2009-01-29

COMPOSITIONS AND METHOD FOR WEIGHT LOSS

#15462
20090028888
2009-01-29

Cancer Antigen Mage-A9 and Uses Thereof

#15463
20090028870
2009-01-29

Treatment of hematologic disorders

#15464
20090028868
2009-01-29

Anti-cancer pharmaceutical compositions and methods for treating patients with cancer

#15465
20090028867
2009-01-29

Antagonists specific for denatured collagen and methods of using same

#15466
20090028857
2009-01-29

PD-1 ANTIBODIES IN COMBINATION WITH A CYTOKINE-SECRETING CELL AND METHODS OF USE THEREOF

#15467
20090028840
2009-01-29

Compositions For Preventing Or Treating Arthritis Comprising Lactic Acid Bacteria and Collangen As Active Ingredients

#15468
20090028831
2009-01-29

STEM CELL REGULATOR, COMPOSITIONS AND METHODS OF USE

#15469
20090028823
2009-01-29

Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases

#15470
20090028820
2009-01-29

Antiviral Agent

#15471
20090028819
2009-01-29

Method for reducing the likelihood of implantation failure during an assisted reproduction in a subject in need thereof

#15472
20090028817
2009-01-29

Compositions and methods for soft tissue augmentation

#15473
20090028816
2009-01-29

Treatment of depression, psychosis, and anxiety

#15474
20090028800
2009-01-29

Method of Treating Postpartum Depression and Aggression

#15475
20090028795
2009-01-29

NOD1 as an Anti-Tumor Agent

#15476
20090023806
2009-01-22

ALUMINUM-STORAGE DISEASE IMPROVING AGENT

#15477
20090023780
2009-01-22

Therapeutic use of a derivative of thienylcyclohexylamine

#15478
20090023778
2009-01-22

Composition Containing Anti-Dementia Drug

#15479
20090023776
2009-01-22

FARNESYL PROTEIN TRANSFERASE INHIBITOR COMBINATIONS WITH ANTIESTROGEN AGENTS

#15480
20090023771
2009-01-22

PHARMACEUTICAL COMPOSITION COMPRISING A PROTON PUMP INHIBITOR AND PROTEIN COMPONENT

#15481
20090023744
2009-01-22

COMBINATION THERAPY FOR DEPRESSION

#15482
20090023714
2009-01-22

COMBINED PREPARATION OF A THIAZIDE DIURETIC AND A LOOP DIURETIC

#15483
20090023712
2009-01-22

Pharmaceutical Compositions for the Treatment of Attention Deficit Hyperactivity Disorder Comprising Flibanserin

#15484
20090023706
2009-01-22

Method of treating organophosphorous poisoning

#15485
20090023705
2009-01-22

Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders or attention deficit disorders

#15486
20090023697
2009-01-22

ANALGESIA METHOD

#15487
20090023694
2009-01-22

Contraceptive

#15488
20090023691
2009-01-22

DELAYING THE AGEING PROCESS AND DISORDERS CAUSED BY AGEING

#15489
20090023684
2009-01-22

FLUID FOR PERITONEAL DIALYSIS

#15490
20090023682
2009-01-22

Composition Comprising Dietary Fat Complexer and Methods of Using Same

#15491
20090023678
2009-01-22

Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds

#15492
20090023677
2009-01-22

Modulation of telomere length in telomerase positive cells and cancer therapy

#15493
20090023668
2009-01-22

Method for treating blepharitis

#15494
20090023663
2009-01-22

Thymosin beta 4 compositions and methods

#15495
20090023656
2009-01-22

Combination comprising combretastatin and anticancer agents

#15496
20090022853
2009-01-22

Beverage

#15497
20090022852
2009-01-22

Liquid Compositions Comprising Non-Digestible Oligosaccharides and Green Tea Catechins

#15498
20090022826
2009-01-22

Multi-step method of pain and/or inflammation treatment

#15499
20090022815
2009-01-22

Halogenated composition, method for preparing same and uses thereof

#15500
20090022814
2009-01-22

CANCER TREATMENT METHOD

#15501
20090022813
2009-01-22

Composition for improving membrane composition and functioning of cells

#15502
20090022810
2009-01-22

EmunoTM Bar, by Nutra-ShieldTM

#15503
20090022801
2009-01-22

Compositions and Methods for Promoting the Healing of Tissue of Multicellular Organisms

#15504
20090022798
2009-01-22

FORMULATIONS OF NONOPIOID AND CONFINED OPIOID ANALGESICS

#15505
20090022796
2009-01-22

Novel Substituted Benzimidazole Dosage Forms and Method of Using Same

#15506
20090022792
2009-01-22

Vitamin D content uniformity in pharmaceutical dosage forms

#15507
20090022790
2009-01-22

Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same

#15508
20090022788
2009-01-22

DIETARY SUPPLEMENT FOR HEALING OR REGRESSING SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE, GASTRITIS AND ULCERS

#15509
20090022786
2009-01-22

Oral pharmaceutical dosage form and manufacturing method thereof

#15510
20090022726
2009-01-22

METHOD OF USING IL6 ANTAGONISTS WITH PROTEASOME INHIBITORS

#15511
20090022718
2009-01-22

Methods of treating vascular inflammatory pathology using anti-TNF antibodies and fragments thereof

#15512
20090022707
2009-01-22

Combinations of antibodies selective for DR5 and other therapeutic agents

#15513
20090022689
2009-01-22

C4-SPIRO-PYRROLIDINE ANTIVIRALS

#15514
20090022687
2009-01-22

Novel Pharmaceuticals That Use Anti-HLA Antibodies

#15515
20090022686
2009-01-22

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SYSTEMIC INFLAMMATORY RESPONSE SYNDROME

#15516
20090022684
2009-01-22

Methods for hematopoietic stimulation

#15517
20090022671
2009-01-22

TREATMENT METHODS

#15518
20090018313
2009-01-15

Enhanced production of blood clotting factors and fibrin fabric

#15519
20090018214
2009-01-15

Composition for promoting vascular smooth muscle relaxation

#15520
20090018205
2009-01-15

Methods for treatment of migraine and symptoms thereof

#15521
20090018200
2009-01-15

COMPOSITION CONTAINING A PHENANTHRENOL

#15522
20090018198
2009-01-15

Method for treating a motoneuron disorder

#15523
20090018196
2009-01-15

FOOD COMPOSITION COMPRISING AMINO ACIDS

#15524
20090018193
2009-01-15

ESSENTIAL FATTY ACIDS IN THE PREVENTION OF CARDIOVASCULAR EVENTS

#15525
20090018190
2009-01-15

Compositions and Methods for Transdermal Oxybutynin Therapy

#15526
20090018164
2009-01-15

FARNESYL PROTEIN TRANSFERASE INHIBITORS FOR TREATING BREAST CANCER

#15527
20090018146
2009-01-15

Combination Therapy with Triterpenoid Compounds and Proteasome Inhibitors

#15528
20090018137
2009-01-15

Modulation of cell fates and activities by phthalazinediones

#15529
20090018136
2009-01-15

METHODS AND COMPOSITIONS FOR THE TREATMENT OF VASCULAR DISEASE

#15530
20090018125
2009-01-15

Pharmaceutical Composition and Its Use

#15531
20090018115
2009-01-15

COMPOSITIONS OF AN ANTICONVULSANT AND AN ANTIPSYCHOTIC DRUG AND METHODS OF USING THE SAME FOR AFFECTING WEIGHT LOSS

#15532
20090018108
2009-01-15

Treating skin hyperpigmentation with dermatological compositions comprising hydroquinone, fluocinolone acetonide and tretinoin

#15533
20090018102
2009-01-15

Phamaceutical/cosmetic compositions comprising hyaluronic acid and treatment of dermatological conditions therewith

#15534
20090018080
2009-01-15

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS

#15535
20090018078
2009-01-15

Apoptosis-Modulating Protein Therapy for Proliferative Disorders and Nanoparticles Containing the Same

#15536
20090018072
2009-01-15

High protein supplement

#15537
20090018061
2009-01-15

Compositions comprising FGF-9 and betacellulin and methods for treating cardiac conditions

#15538
20090018053
2009-01-15

FORMULATIONS FOR AMYLIN AGONIST PEPTIDES

#15539
20090018052
2009-01-15

Treatment of Diabetes and Related Pathologies

#15540
20090017559
2009-01-15

Methods for diagnosing renal disorders

#15541
20090017146
2009-01-15

Beta Vulgaris-Based Products

#15542
20090017145
2009-01-15

Tri ascorbate formulation

#15543
20090017143
2009-01-15

Composition for treatment of alcoholism

#15544
20090017138
2009-01-15

Topical medicament

#15545
20090017136
2009-01-15

Formulation to prevent and treat fibromyalgia, depression and other muscle and nervous system disorders

#15546
20090017129
2009-01-15

Dead Sea minerals enriched anti-inflammatory pharmaceutical composition for treatment of cutaneous dryness, itching, peeling and tightness, especially in hemodialysis patients and preparation and treatment methods thereof

#15547
20090017108
2009-01-15

Liposome compositions for treatment of hepatitis C

#15548
20090017102
2009-01-15

Enhancing transdermal delivery of opioid antagonists and agonists using codrugs linked to bupropion or hydroxybupropion

#15549
20090017089
2009-01-15

Multiple active agents such as anthelmintics sustained release delivery device

#15550
20090017078
2009-01-15

Anhydrous topical formulation for polyphenols

#15551
20090017076
2009-01-15

Treatment for CD5 B cell lymphoma

#15552
20090017075
2009-01-15

Immunomodulatory compositions, methods of making, and methods of use thereof

#15553
20090017071
2009-01-15

METHODS FOR TREATING NEUROGENIC INFLAMMATION

#15554
20090017049
2009-01-15

βGBP, compositions comprising βGBP, and related methods and uses thereof

#15555
20090017036
2009-01-15

PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISORDERS

#15556
20090017025
2009-01-15

Combinations comprising a CDK inhibitor and a growth factor antibody or anti-mitotic

#15557
20090017024
2009-01-15

Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders

#15558
20090017022
2009-01-15

Sulfatases and methods of use thereof

#15559
20090017021
2009-01-15

Methods and compositions for inducing innate immune responses

#15560
20090017007
2009-01-15

LIQUID FACTOR VII COMPOSITION

#15561
20090017006
2009-01-15

USE OF A COMPOUND FOR ENHANCING THE EXPRESSION OF MEMBRANE PROTEINS ON THE CELL SURFACE

#15562
20090016996
2009-01-15

HAIR MESENCHYMAL CELLS

#15563
20090016990
2009-01-15

Antimicrobial Compositions

#15564
20090016967
2009-01-15

Compositions and methods for the treatment of respiratory disorders

#15565
20090012605
2009-01-08

Coronary stent that releases medicamentuous composition to prevent and treat restenosis and fabrication process

#15566
20090012172
2009-01-08

Cosmetic/pharmaceutical compositions comprising retinoids and anti-irritants and treatment of keratinization disorders therewith

#15567
20090012169
2009-01-08

Combined use of L-carnitine, acetyle L-carnitine and propionyl L-carnitine for the treatment of oligoasthenoteratospermia

#15568
20090012167
2009-01-08

Omega-3 Fatty Acids and Dyslipidemic Agent for Lipid Therapy

#15569
20090012165
2009-01-08

PHARMACEUTICAL COMBINATION OF NSAID AND PROSTAGLANDIN COMPOUND

#15570
20090012161
2009-01-08

Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor

#15571
20090012141
2009-01-08

Composition and method for making oligo-benzamide compounds

#15572
20090012106
2009-01-08

Methods, compositions, and kits for organ protection during systemic anticancer therapy

#15573
20090012105
2009-01-08

Combination of Mtor Inhibitor and Antipolate Compound

#15574
20090012098
2009-01-08

Method of treating neurodegenerative diseases

#15575
20090012086
2009-01-08

Use of non-peptidic NK1 receptor antagonists for the production of apoptosis in tumour cells

#15576
20090012051
2009-01-08

EXTERNAL PREPARATION

#15577
20090012048
2009-01-08

Methods for diagnosing and treating a mycobacterium avium subspecies paratuberculosis infection

#15578
20090012037
2009-01-08

Antiviral compounds

#15579
20090012036
2009-01-08

Stable S-adenosyl-L-methionine

#15580
20090012018
2009-01-08

Inhibition of pancretic cancer cell growth

#15581
20090012008
2009-01-08

Pharmaceutical Composition for Photodynamic Therapy and a Method for Treating Oncological Diseases by Using Said Composition

#15582
20090011990
2009-01-08

Carbohydrate fraction and use thereof for a flat postprandial glucose response

#15583
20090011988
2009-01-08

Article of manufacture

#15584
20090011976
2009-01-08

Stable Formulations Of Peptides

#15585
20090011078
2009-01-08

NUTRITIONAL COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS

#15586
20090011059
2009-01-08

Ginger Extract For Inhibiting Human Drug Transporters

#15587
20090011054
2009-01-08

Method of inducing liver phase II enzymes

#15588
20090011052
2009-01-08

Anti-HIV medicinal herbs composition, preparation thereof and use of the same

#15589
20090011050
2009-01-08

Skin Treatment Composition And Method

#15590
20090011048
2009-01-08

Dietary Supplement For Promoting Removal Of Heavy Metals From The Body

#15591
20090011047
2009-01-08

PHARMACEUTICAL COMPOSITIONS COMPRISING OF ARSENOUS ACID, ITS SODIUM SALT AND ITS DERIVATIVES INTENDED FOR THE TREATMENT OR UROGENITAL CANCER AND ITS METASTASIS

#15592
20090011045
2009-01-08

Pharmaceutical for Hygienic Administration in the Ear

#15593
20090011042
2009-01-08

Antimicrobial and antiviral composition

#15594
20090011041
2009-01-08

Compositions for Correcting Age Related Changes of a Human Endocrine System and Methods for Producing a Pharmaceutical Form Bases on Said Compositions

#15595
20090011022
2009-01-08

Use of deuterium oxide for treatment of herpes virus-based diseases of the skin

#15596
20090011015
2009-01-08

Method for promoting sleep

#15597
20090011013
2009-01-08

Tacrolimus Combination Products

#15598
20090011005
2009-01-08

Pharmaceuticals compositions containing nanomaterials useful for treating restenotic lesions

#15599
20090010958
2009-01-08

Compositions effective in altering the perception of malodor

#15600
20090010952
2009-01-08

PHARMACEUTICAL COMPOUND FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING CRT OR ERP57 TRANSLOCATION